drugset / Trial / NCT02273505
Comparison of Pharmacokinetics of Dipyridamole in Asasantin Extended Release (ER) and in a Combination of Persantin Immediate Release Tablets and ASA Tablets in Healthy Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
Comparative Pharmacokinetics of Asasantin Extended Release (ER) and of immediate release Persantin tablets combined with Acetyl salicylic acid (ASA) tablets
Timeline
- Start
- 2000-04
- Primary completion
- 2000-05
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dipyridamole | Other / unclassified | 100 mg | — |
| Subject | Dipyridamole | Other / unclassified | 200 mg | — |
| Comparator | Aspirin | Small molecule | 25 mg | — |
Indications
No indication recorded.